ZFP42
Basic information
Region (hg38): 4:187995771-188005046
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZFP42 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 16 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 16 | 2 | 1 |
Variants in ZFP42
This is a list of pathogenic ClinVar variants found in the ZFP42 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-188002833-C-T | not specified | Uncertain significance (Oct 31, 2022) | ||
4-188002896-G-A | not specified | Uncertain significance (Nov 22, 2022) | ||
4-188002994-C-G | not specified | Likely benign (Dec 28, 2022) | ||
4-188002997-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
4-188003060-A-G | not specified | Uncertain significance (May 31, 2023) | ||
4-188003076-C-T | not specified | Uncertain significance (Nov 24, 2021) | ||
4-188003088-C-A | not specified | Uncertain significance (Oct 29, 2021) | ||
4-188003151-C-T | not specified | Uncertain significance (Nov 15, 2021) | ||
4-188003196-A-G | not specified | Uncertain significance (Dec 01, 2022) | ||
4-188003324-A-G | not specified | Uncertain significance (Mar 01, 2024) | ||
4-188003327-A-C | not specified | Uncertain significance (Jan 09, 2024) | ||
4-188003369-A-G | not specified | Uncertain significance (Nov 24, 2021) | ||
4-188003544-G-T | Likely benign (Apr 20, 2018) | |||
4-188003559-G-A | not specified | Uncertain significance (Mar 28, 2024) | ||
4-188003581-G-A | Benign (Apr 20, 2018) | |||
4-188003595-G-A | not specified | Uncertain significance (Mar 06, 2023) | ||
4-188003618-G-A | not specified | Uncertain significance (Dec 02, 2021) | ||
4-188003639-C-T | not specified | Uncertain significance (Jun 24, 2022) | ||
4-188003648-G-A | not specified | Uncertain significance (Jan 16, 2024) | ||
4-188003662-G-T | not specified | Uncertain significance (Jan 23, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ZFP42 | protein_coding | protein_coding | ENST00000326866 | 1 | 9280 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.448 | 194 | 177 | 1.09 | 0.0000106 | 2022 |
Missense in Polyphen | 43 | 51.924 | 0.82813 | 557 | ||
Synonymous | 0.263 | 71 | 73.9 | 0.961 | 0.00000512 | 599 |
Loss of Function |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | ||
East Asian | ||
Finnish | ||
European (Non-Finnish) | ||
Middle Eastern | ||
South Asian | ||
Other |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the reprogramming of X-chromosome inactivation during the acquisition of pluripotency. Required for efficient elongation of TSIX, a non-coding RNA antisense to XIST. Binds DXPas34 enhancer within the TSIX promoter. Involved in ES cell self-renewal (By similarity). {ECO:0000250}.;
- Pathway
- Cardiac Progenitor Differentiation;Preimplantation Embryo
(Consensus)
Recessive Scores
- pRec
- 0.106
Intolerance Scores
- loftool
- 0.465
- rvis_EVS
- 0.17
- rvis_percentile_EVS
- 65.76
Haploinsufficiency Scores
- pHI
- 0.252
- hipred
- N
- hipred_score
- 0.112
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.265
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Zfp42
- Phenotype
- endocrine/exocrine gland phenotype; cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;male gonad development;female gonad development;meiotic cell cycle
- Cellular component
- nuclear chromatin;nucleus;transcription factor complex;cytoplasm;PcG protein complex
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;sequence-specific DNA binding;metal ion binding